This is a working overview of incretin receptor, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-07-29 and is reviewed periodically as new material appears.
质量控制环节关注外观、含量、纯度、有关物质、水分与微生物限度等项目。检测结果需要有对照品和系统适用性数据支持，单次测定不足以判定批次的稳定性。实验室之间方法转移时，色谱柱品牌与梯度差异常导致保留时间漂移，因此方法验证十分必要。
固体状态的 tirzepatide 通常以冻干粉形式保存，推荐在低温、避光、干燥条件下存放，常见区间为 2 至 8 摄氏度，长期保存可考虑更低温度并避免反复冻融。冻融循环会导致肽链聚集或析出，从而影响后续定量结果。容器密封性与湿度控制同样是稳定性研究中反复强调的因素。
溶解操作一般使用注射用水或适宜的水性缓冲液，必要时加入少量助溶剂以改善溶解速度，但应避免剧烈涡旋振荡，因为剪切力可能促进聚集。配制后的溶液在冷藏条件下的稳定时间通常短于固体形态，具体时限取决于浓度、缓冲体系与容器材质。是否加入防腐成分，则取决于用途是否为多次取样。
Development of tirzepatide took place under a research program that sought to test whether simultaneous engagement of two incretin receptors would produce greater metabolic effects than single-receptor agonism. Clinical trials were organized into the SURPASS series for type 2 diabetes and the SURMOUNT series for obesity and weight management. Regulatory clearance for type 2 diabetes came in 2022 in the United States, followed by approval for chronic weight management in 2023. The trial programs reported reductions in glycated hemoglobin and body weight relative to comparators, though long-term cardiovascular and durability data continue to accumulate.
The peptide backbone contains 39 amino acids and includes alpha-aminoisobutyric acid residues, which are not among the standard proteinogenic set. A C20 fatty diacid moiety is attached through a linker, allowing the compound to bind serum albumin and extend its circulation time. This albumin binding is the main reason the molecule supports once-weekly administration rather than more frequent dosing. The measured molecular mass is approximately 4,813 daltons, placing it firmly in the peptide rather than small-molecule class.
| Property | Value | Notes |
|---|---|---|
| 储存温度 | 2 至 8 摄氏度 | 固体粉末，避光密封 |
| 外观 | 白色至类白色冻干粉 | 溶解后为澄清至微乳光 |
| 溶解性 | 易溶于水性缓冲液 | 避免剧烈振荡 |
| 常规纯度方法 | 反相高效液相色谱 | 紫外或质谱检测 |
| 定量方法 | 液相色谱串联质谱 | 配合固相萃取前处理 |
Development began in the 2010s, when researchers modified a GIP-based scaffold to add GLP-1 activity and then attached the fatty diacid to lengthen its half-life. Clinical evaluation proceeded through large phase 3 programmes in type 2 diabetes and in obesity, and regulators in the United States cleared the compound for type 2 diabetes in 2022 and for chronic weight management in 2023. Several cardiovascular and metabolic outcome studies are still reporting, so the picture of long-term benefit and risk is incomplete. Approvals in other regions followed on different timelines.
Tirzepatide is a synthetic peptide of 39 amino acids that carries a C20 fatty diacid side chain attached through a linker. Its molecular formula is C225H348N48O68, and its molecular weight is about 4813 daltons. The compound belongs to the incretin mimetic class and is administered by subcutaneous injection. The fatty acid chain promotes binding to serum albumin, which slows renal clearance and extends the circulation time of the molecule. It was identified during screening of sequences derived from glucose-dependent insulinotropic polypeptide.
Tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor, making it a dual agonist rather than a selective agent. Engagement of the GLP-1 receptor is linked to glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. The relative contribution of the GIP arm remains an active research question; proposed roles include improved insulin sensitivity and altered adipose tissue handling. Receptor occupancy studies suggest the molecule interacts with both targets at circulating concentrations achieved during therapy.
Long-term storage of the solid generally relies on temperatures at or below minus twenty degrees Celsius, while short-term working stocks may be held refrigerated. Light exposure is limited because photodegradation can alter side chains over extended periods. Solutions prepared for analysis are less stable than the dry powder and are typically used within the same working day. Buffer choice matters, since some aqueous conditions favor deamidation or oxidation at specific residues. Stability data are usually generated under defined accelerated conditions and then extrapolated with stated assumptions.
Identity and purity are established with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry for confirmation of the expected mass. Peptide mapping after enzymatic digestion verifies the primary sequence and detects substitutions. Size-exclusion chromatography quantifies aggregates and fragments, which are the impurities most often tracked for peptides of this size. Residual solvents, counterions, and water content fall under separate tests described in pharmacopeial chapters. Circular dichroism or nuclear magnetic resonance may be used in research settings to probe secondary structure, though such methods are less common in routine release testing.
Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its backbone derives from the native glucose-dependent insulinotropic polypeptide sequence, altered at several positions to resist enzymatic cleavage. A fatty diacid group attached through a linker extends plasma residence time by promoting reversible binding to serum albumin. The molecule carries a net negative charge near physiological pH and has a reported molecular weight close to 4813 daltons. These features separate it from shorter incretin analogs and account for its prolonged dosing interval.
Pharmacologically, tirzepatide activates two distinct G protein-coupled receptors: the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. Binding at each target triggers cyclic AMP accumulation and downstream signaling in pancreatic beta cells, adipose tissue and the central nervous system. Because the two pathways overlap only partially, the combined effect on insulin secretion, glucagon suppression and appetite signaling differs from that of selective single-receptor compounds. Affinity is not equal across the two targets, and the clinical meaning of that imbalance remains an area of active study.
=== Gait === The hunched position that often results from complete spinal fusion can have an effect on a person's gait. Increased spinal kyphosis will lead to a forward and downward shift in center of mass (COM). This shift in COM has been shown to be compensated by increased knee flexion and ankle dorsiflexion. The gait of someone with ankylosing spondylitis often has a cautious pattern because they have decreased ability to absorb shock, and they cannot see the horizon.
== Further reading == Abbott G. European and Muscovite: Ivan Kireevsky and the origins of Slavophilism (Cambridge University Press, 1972) Agnew H. Origins of the Czech National Renascence (University of Pittsburgh Press, 1993) Carole R. The Slovenes and Yugoslavism, 1890-1914 (Columbia University Press, 1977) Djokic D. (ed.) Yugoslavism. Histories of a Failed Idea, 1918-1992 (Hurst and Company, 2003) Gasor A., Karl L., Troebst S. (eds.) Post-Panslavismus. Slavizität, Slavische Idee und Antislavismus im 20. und 21. Jahrhundert (Wallstein Verlag, 2014) Geier, Wolfgang (2022). Panslawismus [Pan-Slavism]. Enzyklopädie des europäischen Ostens, vol. 20,4. Klagenfurt: Wieser, ISBN 978-3-99029-535-9. Golub I., Bracewell C. The Slavic Idea of Juraj Krizanic, Harvard Ukrainian Studies 3-4 (1986). Grigorieva, Anna A. (2010). "Pan-Slavism in Central and Southeastern Europe" (PDF). Journal of Siberian Federal University. Humanities & Social Sciences. 3 (1): 13–21. Retrieved 22 September 2018. Kohn, Hans. Nationalism: Its meaning and history (van Nostrand, 1955). Kohn, Hans (1961). "The Impact of Pan-Slavism on Central Europe". The Review of Politics. 23 (3): 323–333. doi:10.1017/s0034670500008767. JSTOR 1405438. S2CID 145066436. Kostya S. Pan-Slavism (Danubian Press, 1981) Osmańczyk, Edmund Jan (2003). "Pan-Slavism". Encyclopedia of the United Nations and International Agreements: N to S. Taylor & Francis. pp. 1762–. ISBN 9780415939232. Retrieved 22 September 2018. Petrovich B.M.
In 1936, Florey received a letter from Hilda stating that their mother Bertha had terminal cancer, so he arranged to travel to Australia with Ethel, Paquita and Charles during the summer break. They travelled on the SS Orsova to Melbourne, where they were met by Bertha, Charlotte, Hilda, Valetta and Hilda's daughter Joan Gardner. In addition to spending time with his family, he visited Peter MacCallum at his laboratory. MacCallum introduced Florey to Roy Douglas (Pansy) Wright, an experimental physiologist, and they arranged for Wright to come to Oxford the following year to assist Florey and Jennings with their work on mucus secretion. Florey then joined Ethel and the children in Adelaide. The family returned to Oxford in October. Bertha died on 27 November. Henceforth, Florey would lead an interdisciplinary team in an attack on a particular problem. Each member of the team tackled a particular aspect in their own way, with simultaneous research along different lines building up a complete picture. This was a manner of collaboration that was practically unknown in the UK at the time. However, the team members, including Florey, all worked on multiple projects at the same time. Florey was strict with his own collaborators, but gave considerable latitude to those working on other aspects of a project. He did not hold team meetings, although he encouraged team members to discuss issues with himself and each other, and he dropped by each laboratory nearly every day to view progress and provide suggestions. The first such project was an investigation of lymphocytes.
3K3A-Activated Protein C (3K3A-APC) is an experimental drug for the treatment of stroke developed by ZZ Biotech, a company founded by Berislav Zlokovic. It is a genetically engineered variant of activated protein C designed to reduce anticoagulant activity while preserving its cytoprotective and anti-inflammatory properties. This recombinant protein is created by substituting three lysine residues with alanines, thereby minimizing the risk of bleeding associated with native activated protein C. 3K3A-APC exerts its therapeutic effects by targeting protease-activated receptor 1 (PAR1) pathway. A Phase 3 clinical trial was scheduled to start when the NIH paused the trial on November 16, 2023, due to concerns about falsification of data in the studies supporting the clinical trial. The drug was also being assessed for the treatment of Alzheimer's disease, and is currently being evaluated by Dermatherix for wound care.
Sources: en.wikipedia.org
Bioinks are essential components of the bioprinting process. They are composed of living cells and enzymatic supplements to nurture an environment that supports the biological needs of the printed tissue. The environment created by the bioink allows for the cell to attach, grow, and differentiate into its adult form. Cell-encapsualting hydrogels are used in extrusion based bioprinting methods, while gelatin MethacryloylGelatin methacrylon (GelMA) and acellular comprised bioinks are most often used in tissue engineering techniques that require cross-linkage and precise structural integrity. It is essential for bioinks to help replicate the external cellular matrix environment that the cell would naturally occur in.
== Personal life == Guillaume was married twice; first to Marlene Williams in 1955, with whom he had two sons. Guillaume's daughter was born in 1980. They divorced in 1984. He married Donna Brown in 1986. The couple had a daughter. He also fathered a daughter by a different mother, who was born in 1950. In 1999, Guillaume suffered a stroke while working on Sports Night at Walt Disney Studios in Burbank, California. The stroke was minor, causing relatively slight damage and little effect on his speech. After six weeks in the hospital, he underwent therapy consisting of walks and gym sessions.
Milk – unprocessed cow's milk is about 4.7% lactose; goat's milk 4.7%; sheep's milk 4.7%; buffalo milk 4.86%; and yak milk 4.93%. Sour cream and buttermilk – if made in the traditional way, this may be tolerable, but most modern brands add milk solids. Yogurt – lactobacilli used in the production of yogurt metabolize lactose to varying degrees, depending on the type of yogurt. Some bacteria found in yogurt also produce their own lactase, which facilitates digestion in the intestines of lactose intolerant individuals. Cheese – The curdling of cheese concentrates most of the lactose from milk into the whey: fresh cottage cheese contains 7% of the lactose found in an equivalent mass of milk. Further fermentation and aging converts the remaining lactose into lactic acid; traditionally made hard cheeses, which have a long ripening period, contain virtually no lactose: cheddar contains less than 1.5% of the lactose found in an equivalent mass of milk. However, manufactured cheeses may be produced using processes that do not have the same lactose-reducing properties. There used to be a lack of standardization on how lactose is measured and reported in food. The different molecular weights of anhydrous lactose or lactose monohydrate result in up to 5% difference. One source recommends using the "carbohydrates" or "sugars" part of the nutritional label as surrogate for lactose content, but such "lactose by difference" values are not assured to correspond to real lactose content.
where U is the elastic energy of the system and a is the crack length. Either the load P or the displacement u are constant while evaluating the above expressions. Irwin showed that for a mode I crack (opening mode) the strain energy release rate and the stress intensity factor are related by:
The Hitachi 917 is an automated biochemistry analyser utilised at medical laboratories to process biological fluid specimens, such as urine, cerebrospinal fluid, and most commonly, blood. Manufactured by Boehringer Mannheim, the Hitachi 917 is a commonly used routine chemical bichromatic analyser. Capable of doing 1200 test/hour with ISE, it is a popular choice among small to medium size laboratories.
Sources: en.wikipedia.org
For services to the Care of Wildlife in Northumberland. Walter Wilson Ross, Conductor, Pension Silver Band, East Lothian. For services to Music. Charles Routledge, Dresser. For services to the Theatre. David Walton Routledge. For services to the community in Hillingdon, Middlesex. Harold Rowling. For services to the community in Westmeston, East Sussex. Shantilal Hirji Ruparell. For services to the community in Harrow, Middlesex. James Edwin Rous Saltonstall. For services to Yachting and to Young People. Anne Mary Sankaran. For services to the community in Oldham, Lancashire. Peter Saunders, Chairman, Groundwork Trust, Merthyr and Cynon. For services to the Environment. Alan Digerson Savage. For services to the Croydon Battle of Britain Memorial and to the Royal Air Force Benevolent Fund. John Robert Savage. For services to the community in Southwell, Nottinghamshire. Leslie Daniel Sayer, . For services to the Telegraphist Air Gunners' Association. Barry Scaplehorn, lately Firefighter, Suffolk County Fire Service. For services to the Fire Services Benevolent Fund. Susan Scarsbrook, Head, Sudbourne Primary School, Lambeth, London. For services to Education. David Andrew Seaman. For services to Association Football. Peter Jonathan Seaman, lately Chief Inspector, Hertfordshire Constabulary. For services to the Police. Sukumar Sen. For services to the community in Lochaber. Dorothy Sewell. For services to the community in Middlesbrough, North Yorkshire. Robert James Shaw. For services to the Fishing Industry. Patrick John Sherwin. For services to Coastal Rowing.
"Naram-Sin, the mighty, king of Agade, when the four quarters together revolted against him, through the love which the goddess Astar showed him, he was victorious in nine battles in one in 1 year, and the kings whom they (the rebels[?]) had raised (against him), he captured. In view of the fact that he protected the foundations of his city from danger, (the citizens of his city requested from Astar in Eanna, Enlil in Nippur, Dagan in Tuttul, Ninhursag in Kes, Ea in Eridu, Sin in Ur, Samas in Sippar, (and) Nergal in Kutha, that (Naram-Sin) be (made) the god of their city, and they built within Agade a temple (dedicated) to him. As for the one who removes this inscription, may the gods Samas, Astar, Nergal, the bailiff of the king, namely all those gods (mentioned above) tear out his foundations and destroy his progeny."
The Christian Science movement is a religious movement within Christianity founded by Mary Baker Eddy that arose in the mid to late 19th century and that led to the founding of The First Church of Christ, Scientist.
=== Alpha === Alpha motor neurons target extrafusal muscle fibers. The motor nerves associated with these neurons innervate extrafusal fibers and are responsible for muscle contraction. These nerve fibers have the largest diameter of the motor neurons and require the highest conduction velocity of the three types.
Sources: en.wikipedia.org
建议在低温、避光、干燥环境中密封保存，常见条件为 2 至 8 摄氏度，长期存放可置于更低温度。应避免反复冻融，并尽量减少容器开启次数。
溶解后的稳定时间通常短于固体形态，受浓度、缓冲液和容器材质影响。冷藏条件下一般只能维持较短时间，具体期限应通过实际稳定性实验确认。
反相高效液相色谱用于纯度与含量测定，液相色谱串联质谱用于生物基质中的定量，体积排阻色谱用于检测聚集体。多种方法结合才能较完整地表征样品。
It binds and activates both the GIP and GLP-1 receptors, making it a dual incretin receptor agonist. Single-receptor GLP-1 agonists act on one target only. The dual profile is the defining pharmacological feature of the molecule.